Urinary Tract Cancer

Bladder cancer is the sixth most common cancer in the United States, excluding certain skin cancers. The American Cancer Society has estimated there will be approximately 69,000 new cases of bladder cancer in the United States each year. It is estimated that annually there will be 15,000 deaths from bladder cancer. Kidney cancer has a slightly lower incidence, with an estimated 61,000 new cases in the United States each year, and will account for a similar number of deaths, approximately 13,000. The incidence and mortality associated with urinary tract cancers have a great impact on society.


Information from the PET/CT scan helps physicians stage urinary tract cancers.


Treatment can be tailored specifically to the patient, depending upon the location and extent of cancer.


Information from the PET/CT scan allows physicians to monitor recurrence.

PET/CT Utilization and Case Studies

PET/CT is a noninvasive test that physicians utilize to stage the entire body for the presence or absence of active tumor, localize the tumor, assess the tumor response to treatment and detect recurrence in treated lesions.

Source: American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer Society; 2011